CAJ: Capitol Health Limited - Summary | Jitta

Capitol Health Limited

AUS:CAJ

Notice
Stock data is unavailable or the company’s delisted.
Price
AU$0.39
Loss Chance
49.4%
4.00JITTA SCORE
486.16%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (47)
Recent Business Performance (43)
Financial Strength (53)
Return to Shareholders (3)
Competitive Advantage (53)
Jitta Signs
Interest Coverage RatioGood
SG&A to SalesDecreasing
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning loss detected in 2024
Operating MarginInconsistent
Debt LevelVery High Long Term Debt
Recent Business PerformanceEarning decline 297.87% in the last quarter (yoy)
CapExVery High
Key Stats
Jitta Score
Jitta Line
4.00
486.16%
1.46
76.75%
1.46
76.75%
3.35
238.35%
0.95
21.47%
0.95
21.47%
COMPANY DESCRIPTION
Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy. It operates various clinics in Victoria, Tasmania, Western Australia, and South Australia under the Capital Radiology brand, as well as under the Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens’ Imaging, Direct Radiology, and Future Medical Imaging Group brand names. The company was incorporated in 2005 and is headquartered in East Melbourne, Australia. As of December 11, 2024, Capitol Health Limited operates as a subsidiary of Integral Diagnostics Limited.